The Application of External Ureteral Catheters in Children With Acute Kidney Injury Caused by Ceftriaxone-Induced Urolithiasis
- 1Department of Pediatric Urology, Xinhua Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China
- 2Children's Urolithiasis Treatment Center of Chinese Health Committee, Shanghai, China
A Corrigendum on
The Application of External Ureteral Catheters in Children With Acute Kidney Injury Caused by Ceftriaxone-Induced Urolithiasis
by Lin, H., Geng, H., Xu, G., Fang, X., He, L., and Xu, M. (2020). Front. Pediatr. 8:200. doi: 10.3389/fped.2020.00200
The order of the authors was incorrectly listed as Maosheng Xu, Hongquan Geng, Guofeng Xu, Xiaoliang Fang, Lei He and Houwei Lin. The correct order is Houwei Lin, Hongquan Geng, Guofeng Xu, Xiaoliang Fang, Lei He and Maosheng Xu. The correct corresponding author is Maosheng Xu xumaosheng@xinhuamed.com.cn.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: external ureteral catheter, acute kidney injury, ceftriaxione, urolithiasis, children
Citation: Lin H, Geng H, Xu G, Fang X, He L and Xu M (2020) Corrigendum: The Application of External Ureteral Catheters in Children With Acute Kidney Injury Caused by Ceftriaxone-Induced Urolithiasis. Front. Pediatr. 8:513. doi: 10.3389/fped.2020.00513
Received: 19 July 2020; Accepted: 20 July 2020;
Published: 02 September 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Lin, Geng, Xu, Fang, He and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maosheng Xu, xumaosheng@xinhuamed.com.cn